Skip to content
ppharmaranks
Menu

Best treatments for aids-related opportunistic infections

9 products may treat aids-related opportunistic infections, spanning FDA drug classes such as herpes simplex virus nucleoside analog dna polymerase inhibitor, herpes zoster virus nucleoside analog dna polymerase inhibitor, herpesvirus nucleoside analog dna polymerase inhibitor. The current highest-rated option is acyclovir sodium. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 9 drugs we list for aids-related opportunistic infections, 7 are available as lower-cost generics, spanning classes such as herpes simplex virus nucleoside analog dna polymerase inhibitor, herpes zoster virus nucleoside analog dna polymerase inhibitor, herpesvirus nucleoside analog dna polymerase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for aids-related opportunistic infections — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for aids-related opportunistic infections: 1. Acyclovir Sodium · 2. Valganciclovir Hydrochloride · 3. Pyrimethamine

Top-rated treatments for aids-related opportunistic infections, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$5View →
270/100$56View →
368/100$4110View →
456/100$5View →
5Not yet rated$24View →
6Not yet ratedView →
7Not yet rated$4110View →
8Not yet rated$56View →
9Not yet ratedView →

Full ranking · 9 treatments

#1 of 4 in Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor

acyclovir sodium

PrescriptionFDA-sourced

70/100

Acyclovir Sodium is a herpes simplex virus nucleoside analog dna polymerase inhibitor used to treat Chickenpox, Herpes Genitalis, Herpes Labialis, Herpes Zoster Ophthalmicus.

(8 data points)
herpes simplex virus nucleoside analog dna polymerase inhibitorherpes zoster virus nucleoside analog dna polymerase inhibitorherpesvirus nucleoside analog dna polymerase inhibitor

Pharmacy pays

From ~$2.22/30· 6 forms
View details →

valganciclovir hydrochloride

Boxed warning

PrescriptionFDA-sourced

70/100

Valganciclovir Hydrochloride is a cytomegalovirus nucleoside analog dna polymerase inhibitor used to treat Aids-Related Opportunistic Infections, Cytomegalovirus Retinitis.

(3 data points)
cytomegalovirus nucleoside analog dna polymerase inhibitornucleoside analog antiviralaids-related opportunistic infections

Pharmacy pays

From ~$38.57/30· 2 forms
View details →

pyrimethamine

PrescriptionFDA-sourced

68/100

Pyrimethamine is a dihydrofolate reductase inhibitor antimalarial used to treat Toxoplasmosis, Falciparum Malaria, Aids-Related Opportunistic Infections.

(29 data points)
dihydrofolate reductase inhibitor antimalarialtoxoplasmosismalaria, falciparum

Pharmacy pays

~$4110.26 /30

View details →

acyclovir

PrescriptionFDA-sourced

56/100

Acyclovir is a herpes simplex virus nucleoside analog dna polymerase inhibitor used to treat Chickenpox, Herpes Genitalis, Herpes Labialis, Herpes Zoster Ophthalmicus.

(124 data points)
herpes simplex virus nucleoside analog dna polymerase inhibitorherpes zoster virus nucleoside analog dna polymerase inhibitorherpesvirus nucleoside analog dna polymerase inhibitor

Pharmacy pays

From ~$2.22/30· 6 forms
View details →

aczone

PrescriptionFDA-sourced

New

Aczone (Dapsone) is a sulfone used to treat Dermatitis Herpetiformis, Relapsing Polychondritis, Lepromatous Leprosy, Aids-Related Opportunistic Infections.

sulfonedermatitis herpetiformispolychondritis, relapsing

Pharmacy pays

From ~$15.57/30· 4 forms
View details →

ancobon

Boxed warning

PrescriptionFDA-sourced

New

Ancobon (Flucytosine) is a nucleoside analog antifungal used to treat Aspergillosis, Candidiasis, Chromoblastomycosis, Cryptococcal Meningitis.

nucleoside analog antifungalaspergillosiscandidiasis
Available online
View details →

Frequently asked

What treats aids-related opportunistic infections?
Our catalog lists 9 products that may treat aids-related opportunistic infections, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is acyclovir sodium.
What is the best-rated treatment for aids-related opportunistic infections?
By our independent recall-safety rating — not an efficacy measure — acyclovir sodium ranks highest among the products we list for aids-related opportunistic infections. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat aids-related opportunistic infections?
Treatments for aids-related opportunistic infections span FDA drug classes including herpes simplex virus nucleoside analog dna polymerase inhibitor, herpes zoster virus nucleoside analog dna polymerase inhibitor, herpesvirus nucleoside analog dna polymerase inhibitor, cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.